⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9798002 | 1.00 | — | — | |
| SCHEMBL3598285 | 1.00 | — | — | |
| SCHEMBL4730601 | 0.79 | — | — | |
| SCHEMBL1676698 | 0.74 | — | — | |
| SCHEMBL1676699 | 0.74 | — | — | |
| SCHEMBL11277663 | 0.74 | — | — | |
| SCHEMBL5579074 | 0.72 | — | — | |
| SCHEMBL3390700 | 0.72 | — | — | |
| SCHEMBL9632102 | 0.72 | — | — | |
| SCHEMBL7518752 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1041888-B1 | ANTI-RETROVIRAL IMMUNOGENS, PREPARATION AND USE | NEOVACS (FR) | 2008-10-22 | — | — | EP | disclosed |
| EP-1975173-A1 | Anti-Retroviral Immunogens, Preparation and Use | NEOVACS (FR) | 2008-10-01 | — | — | EP | disclosed |
| US-7022326-B1 | Carboxymethylated retroviral regulatory proteins and interferon-α | BIOVACS, INC. (US) | 2006-04-04 | — | — | US | disclosed |
| EP-1041888-A4 | ANTI-RETROVIRAL IMMUNOGENS, PREPARATION AND USE | ZAGURY JEAN FRANCOIS (FR) | 2000-10-18 | — | — | EP | disclosed |
| EP-1041888-A1 | ANTI-RETROVIRAL IMMUNOGENS, PREPARATION AND USE | ZAGURY, Jean-François (FR) | 2000-10-11 | — | — | EP | disclosed |
| WO-1999033346-A1 | ANTI-RETROVIRAL IMMUNOGENS, PREPARATION AND USE | BIOVACS. INC. (US) | 1999-07-08 | — | — | WO | disclosed |